¿Diferen la insulina humana totalmente sintética y la sintetizada genéticamente?

Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

Diabetic medicine : a journal of the British Diabetic Association·2011

The effect of GH replacement therapy on different fat compartments: a whole-body magnetic resonance imaging study.

European journal of endocrinology·2010

Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2010

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.

Diabetic medicine : a journal of the British Diabetic Association·2009

A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.

Diabetes, obesity & metabolism·2009

[Role of complementary medicine in type 1 diabetes mellitus in two Swiss centres].

Praxis·2009

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Closing the implementation gap: a harmonised EU framework for synthetic nucleic acid screening and customer verification.

Frontiers in bioengineering and biotechnology·2026

Ubiquitin-elongating enzyme Ufd2 confers resistance to hygromycin B in <i>Saccharomyces cerevisiae</i>.

microPublication biology·2026

Synthesis and Evaluation of Iminosugar-Based Analogs of UDP-GlcNAc as Putative OGT Inhibitors.

ChemMedChem·2026

Development of UV-induced mutants of Scenedesmus obliquus with enhanced lipid content for sustainable biofuel production.

World journal of microbiology & biotechnology·2026

Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry.

mAbs·2026

Synthetic Small Molecules as Regulators of In Vitro Multiplication in <i>Selenicereus</i> Hybrids.

Plants (Basel, Switzerland)·2026

Videos de Experimentos Relacionados

¿Diferen la insulina humana totalmente sintética y la sintetizada genéticamente?

Videos de Conceptos Relacionados

Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

The effect of GH replacement therapy on different fat compartments: a whole-body magnetic resonance imaging study.

Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.

A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.

[Role of complementary medicine in type 1 diabetes mellitus in two Swiss centres].

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Closing the implementation gap: a harmonised EU framework for synthetic nucleic acid screening and customer verification.

Ubiquitin-elongating enzyme Ufd2 confers resistance to hygromycin B in <i>Saccharomyces cerevisiae</i>.

Synthesis and Evaluation of Iminosugar-Based Analogs of UDP-GlcNAc as Putative OGT Inhibitors.

Development of UV-induced mutants of Scenedesmus obliquus with enhanced lipid content for sustainable biofuel production.

Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry.

Synthetic Small Molecules as Regulators of In Vitro Multiplication in <i>Selenicereus</i> Hybrids.

Videos de Experimentos Relacionados

¿Diferen la insulina humana totalmente sintética y la sintetizada genéticamente?

Videos de Conceptos Relacionados

Artículos Relacionados